When.com Web Search

  1. Ads

    related to: treatment for lupus erythematosus

Search results

  1. Results From The WOW.Com Content Network
  2. Lupus - Wikipedia

    en.wikipedia.org/wiki/Lupus

    Lupus, formally called systemic lupus erythematosus (SLE), is an autoimmune disease in which the body's immune system mistakenly attacks healthy tissue in many parts of the body. [1] Symptoms vary among people and may be mild to severe. [ 1 ]

  3. Lupus erythematosus - Wikipedia

    en.wikipedia.org/wiki/Lupus_erythematosus

    Lupus erythematosus is a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. [1] Symptoms of these diseases can affect many different body systems, including joints , skin , kidneys , blood cells , heart , and lungs .

  4. Anifrolumab - Wikipedia

    en.wikipedia.org/wiki/Anifrolumab

    Anifrolumab, sold under the brand name Saphnelo, is a monoclonal antibody used for the treatment of systemic lupus erythematosus. [5] [7] It binds to the type I interferon receptor, blocking the activity of type I interferons such as interferon-α and interferon-β. [medical citation needed]

  5. Discoid lupus erythematosus - Wikipedia

    en.wikipedia.org/wiki/Discoid_lupus_erythematosus

    Discoid lupus erythematosus is the most common type of chronic cutaneous lupus (CCLE), an autoimmune skin condition on the lupus erythematosus spectrum of illnesses. [1] [2] It presents with red, painful, inflamed and coin-shaped patches of skin with a scaly and crusty appearance, most often on the scalp, cheeks, and ears.

  6. Aurinia's Lupkynis Shows Treatment Benefit In Lupus ... - AOL

    www.aol.com/news/aurinias-lupkynis-shows...

    Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has presented additional efficacy data from the AURA-LV and AURORA 1 trials of Lupkynis (voclosporin) in lupus nephritis (LN). Aurinia shared the data at ...

  7. Belimumab - Wikipedia

    en.wikipedia.org/wiki/Belimumab

    Under the brand name Benlysta, belimumab received FDA approval for the treatment of systemic lupus erythematosus in March 2011, [33] despite concerns among advisory committee members that the improvement of 4 points on the SELENA-SLEDA scale was marginal, and despite reservations about additional deaths in the treatment group.

  1. Ads

    related to: treatment for lupus erythematosus